
( (S 
    (NP-SBJ 
      (NP (NNP Oncor) (NNP Inc.) )
      (, ,) 
      (NP 
        (NP (NNP Gaithersburg) )
        (, ,) 
        (NP (NNP Md.) ))
      (, ,) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP it) )
          (VP (VBD received) 
            (NP 
              (NP (NN approval) 
                (S (-NONE- *ICH*-2) ))
              (PP (IN from) 
                (NP (DT the) (NNP U.S.) (NNP Food) 
                  (CC and)
                  (NNP Drug) (NNP Administration) ))
              (S-2 
                (NP-SBJ (-NONE- *) )
                (VP (TO to) 
                  (VP (VB market) 
                    (NP 
                      (NP (DT a) (JJ genetic) (NN test) )
                      (SBAR 
                        (WHNP-1 (WDT that) )
                        (S 
                          (NP-SBJ (-NONE- *T*-1) )
                          (VP (MD will) 
                            (VP (VB assist) 
                              (PP-LOC-CLR (IN in) 
                                (NP 
                                  (NP (NN diagnosis) 
                                    (CC and)
                                    (NN treatment) )
                                  (PP (IN of) 
                                    (NP 
                                      (NP (NN leukemia) )
                                      (CC and) 
                                      (NP (NN lymph) (NN cancer) ))))))))))))))))))
    (. .) ))
( (SINV 
    (S-TPC-1 
      (NP-SBJ (DT The) (NNP B\/T) (NN gene) (NN rearrangement) (NN test) )
      (VP (VBZ is) 
        (ADJP-PRD 
          (ADJP (RBR more) (JJ accurate) )
          (PP (IN than) 
            (NP (VBG existing) (NNS tests) )))
        (PP (IN for) 
          (S-NOM 
            (NP-SBJ (-NONE- *) )
            (VP (VBG diagnosing) 
              (NP 
                (NP 
                  (NP (DT the) (NN type) )
                  (PP (IN of) 
                    (NP (NN cancer) )))
                (, ,) 
                (SBAR 
                  (SBAR (IN whether) 
                    (S 
                      (NP-SBJ (PRP it) )
                      (VP (VBZ has) 
                        (VP (VBN spread) ))))
                  (CC or) 
                  (SBAR (IN whether) 
                    (S 
                      (NP-SBJ (EX there) )
                      (VP (VBZ is) 
                        (NP-PRD 
                          (NP (DT a) (NN recurrence) )
                          (VP (VBG following) 
                            (NP (NN treatment) )))))))))))))
    (, ,) 
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (NP-SBJ (NNP Oncor) (NNP President) (NNP Stephen) (NNP Turner) )
    (. .) ))
( (S 
    (NP-SBJ (NNP Mr.) (NNP Turner) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) (NN test) )
          (VP 
            (VP 
              (ADVP-PRP (RB initially) )
              (MD will) 
              (VP (VB be) 
                (VP (VBN used) 
                  (PP-MNR (IN in) 
                    (NP 
                      (NP (NN conjunction) )
                      (PP (IN with) 
                        (NP 
                          (NP (NNS biopsies) )
                          (CC and) 
                          (NP (JJ other) (NNS tests) ))))))))
            (, ,) (CC but) 
            (VP 
              (ADVP-TMP (RB eventually) )
              (MD might) 
              (VP (VB become) 
                (NP-PRD 
                  (NP (DT the) (NN benchmark) )
                  (PP (IN for) 
                    (NP (NN tumor) (NN analysis) )))))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Mr.) (NNP Turner) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ-1 (DT the) (NN test) )
          (VP (MD will) 
            (VP (VB be) 
              (VP (VBN shipped) 
                (NP (-NONE- *-1) )
                (PP-TMP (IN in) 
                  (NP (CD 45) (NNS days) ))
                (PP-DIR (TO to) 
                  (NP 
                    (NP (NNS hospitals) )
                    (CC and) 
                    (NP (JJ clinical) (NNS laboratories) )))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Dr.) (NNP Wyndham) (NNP Wilson) )
      (, ,) 
      (NP 
        (NP (DT a) (NN cancer) (NN treatment) (NN specialist) )
        (PP (IN at) 
          (NP (DT the) (NNP National) (NNP Cancer) (NNP Institute) )))
      (, ,) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) (NN test) )
          (VP 
            (VP (VBZ is) 
              (VP 
                (ADVP (RB widely) )
                (VBN used) 
                (PP-LOC-CLR (IN in) 
                  (NP (NN research) (NNS centers) ))))
            (CC but) 
            (VP (VBZ is) (RB n't) 
              (VP (VBG having) 
                (NP (DT a) (JJ major) (NN impact) )
                (SBAR-PRP (IN because) 
                  (S 
                    (NP-SBJ (PRP it) )
                    (VP (VBZ is) 
                      (ADJP-PRD 
                        (ADVP (RB only) (RB occasionally) )
                        (JJ useful) 
                        (PP (IN in) 
                          (S-NOM 
                            (NP-SBJ (-NONE- *) )
                            (VP (VBG choosing) 
                              (NP (DT the) 
                                (ADJP (JJS most) (JJ effective) )
                                (NN treatment) ))))))))))))))
    (. .) ))
( (S 
    (S-TPC-2 (CC But) 
      (NP-SBJ-1 (DT the) (NN test) )
      (VP (MD may) 
        (VP (VB prove) 
          (S 
            (NP-SBJ (-NONE- *-1) )
            (VP (TO to) 
              (VP (VB be) 
                (ADJP-PRD (RBR more) (JJ sensitive) 
                  (PP (IN in) 
                    (S-NOM 
                      (NP-SBJ (-NONE- *) )
                      (VP (VBG determining) 
                        (SBAR (IN whether) 
                          (S 
                            (NP-SBJ (DT a) (NN tumor) )
                            (VP (VBZ has) 
                              (VP (VBN spread) (CC or) (VBN returned) 
                                (PP (VBG following) 
                                  (NP (NN treatment) ))))))))))))))))
    (, ,) 
    (NP-SBJ (NNP Dr.) (NNP Wilson) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 
      (NP-SBJ (PRP We) )
      (VP (VBP do) (RB n't) 
        (VP (VB know) 
          (ADVP-TMP (RB yet) )
          (SBAR 
            (WHADVP-2 (WRB how) 
              (ADJP (JJ useful) ))
            (S 
              (NP-SBJ (PRP it) )
              (VP (VBZ 's) 
                (VP (VBG going) 
                  (S 
                    (NP-SBJ (-NONE- *) )
                    (VP (TO to) 
                      (VP (VB be) 
                        (ADVP-PRD (-NONE- *T*-2) )))))))))))
    (, ,) ('' '') 
    (NP-SBJ (PRP he) )
    (VP (VBD said) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (S-TPC-1 
      (NP-SBJ 
        (NP (NNP Oncor) )
        (, ,) 
        (NP 
          (NP (DT a) (JJ six-year-old) (NN developer) )
          (PP (IN of) 
            (NP (JJ genetic) (JJ medical) (NNS tests) )))
        (, ,) )
      (VP (VBZ projects) 
        (SBAR (IN that) 
          (S 
            (NP-SBJ (DT the) (NN cancer) (NN test) )
            (VP (MD will) 
              (VP (VB help) 
                (NP (PRP it) )
                (S 
                  (NP-SBJ (-NONE- *) )
                  (VP (TO to) 
                    (VP (VB post) 
                      (NP (PRP$ its) (JJ first-ever) (NN profit) )
                      (PP-TMP (IN during) 
                        (NP 
                          (NP (DT the) (JJ first) (NN quarter) )
                          (PP (IN of) 
                            (NP (CD 1990) )))))))))))))
    (, ,) 
    (NP-SBJ (NNP Mr.) (NNP Turner) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S 
    (S-TPC-1 
      (NP-SBJ (DT The) (NN company) )
      (VP 
        (VP (MD will) 
          (VP (VB charge) 
            (NP ($ $) (CD 35) (-NONE- *U*) )
            (PP-CLR (IN for) 
              (NP (DT a) (NN test) ))))
        (CC and) 
        (VP (VBZ projects) 
          (NP 
            (NP (IN about) 
              (QP ($ $) (CD 2) (CD million) )
              (-NONE- *U*) )
            (PP (IN in) 
              (NP (NN revenue) ))
            (PP (IN from) 
              (NP (DT the) (NN test) ))
            (PP-TMP (IN during) 
              (NP 
                (NP (DT the) (JJ first) (CD 12) (NNS months) )
                (PP (IN of) 
                  (NP (NN marketing) ))))))))
    (, ,) 
    (NP-SBJ (PRP he) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
